Modulation of eosinophil survival by epinastine hydrochloride, an H1 receptor antagonist, in vitro

In Vivo

Volumn 22, Issue 6, 2008, Pages 687-692

  Watase, Fumitaka ^a   Watanabe, So ^a   Kanai, Ken Ichi ^a   Yamada, Naohiro ^a   Sakaue, Satoshi ^a   Asano, Kazuhito ^a   Hisamitsu, Tadashi ^a   Suzaki, Harumi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Eosinophil; Epinastine hydrochloride; H1 receptor antagonist; Nasal epithelial cells

Indexed keywords

EPINASTINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRYPAN BLUE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL STIMULATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL COUNT; HUMAN; HUMAN CELL; IN VITRO STUDY; MUCOSA CELL; NOSE MUCOSA;

EID: 57849119283     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rothenberg ME and Hogan SP: The eosinophil. Annu Rev Immunol 24: 147-174, 2006.
2. Malm-Erjefalt M, Persson CGA and Erjefalt JS: Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol 24: 352-359, 2001.
3. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105: 651-663, 2000.
4. Overbeek SE, O'Sullivan S, Leman K, Mulder PG, Hooqsteden HC and Prins JB: Effect of montelukast compared with inhaled fluticasone on airway inflammation. Clin Exp Allergy 34: 1388-1394, 2004.
5. Davoine F, Fernand C, Chakir J, Lee JE, Adamko DJ, Moqbel R and Laviolette M: Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis. Int Arch Allergy Immunol 140: 277-284, 2006.
6. Petsky HL, Kynaston JA, Turner C, Li AM, Cates CJ, Lasserson TJ and Chang AB: Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 18: CD005603, 2007.
7. Matsumoto K, Tamari M and Saito H: Involvement of eosinophils in the onset of asthma. J Allergy Clin Immunl 121: 26-27, 2008.
8. 1 receptor antagonist, epinastine (WASL 801 CL), on isolated human allergic effector cells. Inflammation Res 49: 112-116, 2000.
9. Matsukura M, Yajima A, Yamazaki F, Yudate T, Yamabe H and Tezuka T: Epinastine inhibits eosinophil chemotaxis and adhesion molecules in atopic dermatitis. Skin Pharmacol Appl Skin Physiol 16: 405-410, 2003.
10. Mochizuki Y, Furuta A, Furuya A, Kanai K, Asano K and Suzaki H: Suppressive activity of epinastine hydrochrolide on eosinophil activation in vitro. In Vivo 22: 13-20, 2008.
11. Mullol J, Lopez E, Roca-Ferrer J, Xaubet A, Pujols L, Fernandez-Morata JC, Fabra JM and Picado C: Effect of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Clin Exp Allergy 27: 1432-1441, 1997.
12. Xaubet A, Mullol J, Roca-Ferrer J, Pujols L, Pujol L, Perez M, Fabra JM and Picado C: Effect of budesonide and nedcromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells. Respir Med 95: 408-414, 2001.
13. Bachert C, Hormann K, Mosges R, Rasp G, Riechelmann H, Muller R, Luckhaupt H, Stuck BA and Rudack C: An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 58: 176-191, 2003.
14. Asano K, Kanai K and Suzaki H: Suppressive activity of fexofenadine hydrochloride on thymus- and activation-regulated chemokine production from human peripheral blood leukocytes in response to antigenic stimulation in vitro. Int Arch Allergy Immunol 133: 267-275, 2004.
15. Kanai K, Asano K, Watanabe S, Kyo Y and Suzaki H: Epinastine hydrochloride antagonism against interleukin-4-mediated T-cell cytokine imbalance in vitro. Int Arch Allergy Immunol 140: 43-52, 2006.
16. Asano K, Kanai K, Furuta A, Furuya A, Suzaki H and Hisamitsu T: Suppressive activity of fexofenadine hydrochloride on nitric oxide production in vitro and in vivo. J Pharm Pharmacol 59: 1389-1395, 2007.
17. Roberts RL and Gallin JI: Rapid method for isolation of normal peripheral blood eosinophil on discontinuous percoll gradients and comparison with neutrophils. Blood 65: 433-440, 1985.
18. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Danzig M and Canonica GW: Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. Clin Exp Allergy 27: 1175-1183, 1997.
19. Agrawal DK and Berro AI: Effect of desloratadine on the apoptosis of human blood eosinophils. Abstract book of the XXII Congress of the European Academy of Allergology and Clinical Immunology abstract 955, 2003.
20. Domae M, Sagara H, Sakaue M, Fukuda T and Kamikawa Y: The antiallergic drug oxatomide promotes human eosinophil apoptosis and suppresses IL-5-induced eosinophil survival. J Allergy Clin Immunol 111: 567-572, 2003.
21. Galotowicz G, Ajayi Y, Stern ME and Calder VL: Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Clin Exp Allergy 37: 1648-1656, 2007.
22. Tasaka K: Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases. Drug Today 36: 735-757, 2007.
23. Mullol J, Xaubet A, Gaya A, Roca-Fener J, Lopez E, Fernandez JC and Picado C: Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 25: 607-615, 1995.
24. Mullol J, Roca-Ferrer J, Alobid I, Pujols L, Valero A, Xaubet A, Bernal-Sprekelsen M and Picado C: Effect of desloratadine on epithelial cell granulocyte macrophage colony-stimulating factor secretion and eosinophil survival. Chin Exp Allergy 36: 52-58, 2006.
25. Solomon A, Shmilowich R, Shasha D, Frucht-Pery J, Pe'er J, Bonini S and Levi-Schaffer F: Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro. Invest Opthalmol Vis Sci 41: 1038-1044, 2000.
26. Roca-Ferroe J, Mullol J, Xaubet A, Benitez P, Bernal-Sprekelsen M, Shelhamer J and Picado C: Proinflammatory cytokines and eosinophil cationic protein on glandular secretion from human nasal mucosa: regulation by corticosteriods. J Allergy Clin Immunol 108: 87-93, 2001.